[68Ga]FAPI PET/CT reveals increased pulmonary fibroblast activation protein expression in long COVID patients after ICU discharge
- PMID: 40542858
- DOI: 10.1007/s00259-025-07376-y
[68Ga]FAPI PET/CT reveals increased pulmonary fibroblast activation protein expression in long COVID patients after ICU discharge
Abstract
Purpose: Post-acute sequelae of COVID-19 (PASC) has emerged as a major healthcare problem. A comprehensive mechanism of disease remains to be elucidated. In this study we aimed to explore pulmonary and muscle fibroblast activation protein (FAP) activity in former critical COVID-19 patients with persistent dyspnea, using [68Ga]FAPI-46 PET/CT.
Methods: In this single center prospective observational study we included former critical COVID-19 patients reporting complaints of dyspnea > 3 months after hospital discharge. A [68Ga]FAPI PET/CT scan was performed including a high-resolution CT scan, lung function test, EQ-5D questionnaire, 6 min walking test and inflammatory markers. Age and sex-matched subjects, without pulmonary pathology, served as controls. The [68Ga]FAPI uptake was corrected for lean body mass and the target-to-background ratio (TBR) was calculated.
Results: Eighteen PASC patients and 15 controls (median age 59 and 63 years and BMI of 34.6 and 25.2 kg/m2) were included. The interval between hospital discharge and study visit was 30 months. Increased pulmonary FAP expression was observed in PASC, (TBR 0.79 ± 0.23) compared to controls (TBR 0.40 ± 0.13, P < 0.001). Increased FAP expression was also observed in the paravertebral muscles (PASC: TBR 1.17 and controls TBR 1.00, P = 0.03). Forced expiratory volume and forced vital capacity showed moderate negative correlation with the pulmonary TBR, while the percentage of ground glass opacities showed a moderate positive correlation.
Conclusion: [68Ga]FAPI PET/CT demonstrated elevated FAP expression in PASC. These findings provide insight into possible pathophysiological mechanisms of PASC and a potential new diagnostic modality.
Keywords: Critically ill; FAPI PET/CT; Long COVID; Muscles; Post-acute sequalae of COVID-19; Respiratory.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethical approval: The study protocol was approved by the Institution Review Board of the University Medical Center Groningen (202100802) and registered at ClinicalTrials.gov (NCT05981885). The study was performed in accordance with the Declaration of Helsinki. All patients provided written informed consent. Competing interests: Janesh Pillay is supported by a research grant from the Netherlands Organization for Health Research and Development, The Netherlands (ZonMw Clinical Fellowship grant 09032212110044) and has received funding from ‘a Partnership of Siemens and UMCG for building the future of Health’ (PUSH MO24.00027). The other authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. Riemer Slart is an associate editor for EJNMMI. Information regarding FAPI-46 precursor composition used in this study containing approximately 20% of the non-binding (R)-enantiomer was provided by GE HealthCare and incorporated in this manuscript.
References
-
- Ballering AV, van Zon SKR, olde Hartman TC, Rosmalen JGM. Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. Lancet. 2022 [cited 2024 Jun 26];400:452–61. https://doi.org/10.1016/S0140-6736(22)01214-4 .
-
- Hodgson CL, Broadley T. Long COVID—unravelling a complex condition. Lancet Respir Med. 2023 [cited 2024 Feb 23];11:667–8. https://doi.org/10.1016/S2213-2600(23)00232-1 .
-
- Thaweethai T, Jolley SE, Karlson EW, Levitan EB, Levy B, McComsey GA, et al. Development of a definition of postacute sequelae of SARS-CoV-2 infection. JAMA. 2023 [cited 2024 Apr 23];329:1934–46. https://doi.org/10.1001/JAMA.2023.8823 .
-
- Gentilotti E, Górska A, Tami A, Gusinow R, Mirandola M, Rodríguez Baño J, et al. Clinical phenotypes and quality of life to define post-COVID-19 syndrome: a cluster analysis of the multinational, prospective ORCHESTRA cohort. EClinicalMedicine. 2023 [cited 2024 Feb 23];62. https://doi.org/10.1016/j.eclinm.2023.102107 .
-
- Bazdar S, Kwee AKAL, Houweling L, de Wit-van Wijck Y, Mohamed Hoesein FAA, Downward GS, et al. A Systematic Review of Chest Imaging Findings in Long COVID Patients. J Pers Med. 2023 [cited 2024 Feb 23];13. https://doi.org/10.3390/JPM13020282/S1 .
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous